$13.520
-0.853 (-6.31%)終値時点
TRXB の同業比較
In the context of the broader market, TRXB competes directly with industry leaders such as RZLT and AVTX. With a market capitalization of $396.04M, it holds a significant position in the sector. When comparing efficiency, TRXB's gross margin of N/A stands against RZLT's N/A and AVTX's N/A. Such benchmarking helps identify whether TRex Bio, Inc. is trading at a premium or discount relative to its financial performance.
TRex Bio, Inc. Common stock の財務パフォーマンス
The financial metrics show a P/E ratio of 0 and a forward P/E of 0, suggesting no earnings expectations. The EV to EBITDA is negative at -8.61, indicating potential issues with profitability.
Financials
No data
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。